PI3K

A nostalgic steam train travels through a snowy winter forest in Geesthacht Germany

Biotech

Relay ‘full steam ahead’ on PI3K drug after rare disease readout

Relay’s R&D chief remains convinced zovegalisib will carve out its own niche after reporting early phase 2 data in patients with vascular anomalies.

Will Maddox May 19, 2026 6:00am

Businessman climbing steps to pluck a star from the sky

Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 study

May 4, 2026 8:06am

Sensei steps back from brink by finding Faeth merger

Feb 18, 2026 10:33am

illustration of venture capital investment funding

Incyte vets raise $102M to create better PARP, PI3K drugs

Jan 24, 2024 8:38am

IPO

Adlai bags $57.5M IPO to test ex-Novartis cancer drug in phase 3

Sep 29, 2023 10:00am

earnings Q1 calendar

2 more biotechs report pipeline, partnership changes

May 12, 2023 11:15am